<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02762968</url>
  </required_header>
  <id_info>
    <org_study_id>MTI2016-CS02</org_study_id>
    <nct_id>NCT02762968</nct_id>
  </id_info>
  <brief_title>The Effects of Probiotic and HMB Supplementation on Immune and Digestive Function in Special Operations Soldiers</brief_title>
  <official_title>The Effects of 8-weeks of Probiotic and HMB Supplementation on Immune and Digestive Function in Special Operations Soldiers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Metabolic Technologies Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Central Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Metabolic Technologies Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will determine whether acute ingestion of a probiotic combined with
      beta-hydroxy-beta-methylbutyrate (HMB) can enhance immune and digestive function in soldiers
      during 8-weeks of advanced infantry training.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Up to sixty soldiers from an elite infantry unit will perform a parallel design
      investigation. Soldiers will be randomly assigned to one of four groups. Group 1 will consume
      the probiotic plus HMB, group 2 will consume HMB only, group 3 will consume only the
      probiotic, and group 4 will consume only placebo. All four groups will be garrisoned
      together, eat the same meals, and perform the same activity. All groups will be tested before
      as well as after an 8-week advanced infantry training program. During each testing session
      resting blood samples will be obtained to assess cytokine, inflammatory, and muscle damage
      markers. Additionally, questionnaires will be used to determine digestive health.
      Anthropometric, performance, and muscle volume measures will also be assessed prior to and
      immediately following the supplementation and training protocol.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maintenance of Immune function</measure>
    <time_frame>8 weeks</time_frame>
    <description>Immune function assessed by blood biochemical analysis (ELISA).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maintenance of Digestive Function</measure>
    <time_frame>8 Weeks</time_frame>
    <description>Digestive function assessed by questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maintenance of Muscle Volume</measure>
    <time_frame>8 Weeks</time_frame>
    <description>Muscle volume will be assessed using a 3.0 Tesla whole-body imager (cubic centimeter)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Military Training</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo capsules similar to the experimental treatments.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HMB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HMB capsules providing 3 g of calcium HMB per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HMB + BC30</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Capsules providing 3 g calcium HMB per day plus Bacillus Coagulans GBI-30, 6086 (BC30) mixed in water.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo capsules similar to the experimental treatments.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HMB</intervention_name>
    <description>Capsules containing calcium HMB.</description>
    <arm_group_label>HMB</arm_group_label>
    <arm_group_label>HMB + BC30</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>BC30</intervention_name>
    <description>Bacillus Coagulans GBI-30, 6086 (BC30) mixed in water.</description>
    <arm_group_label>HMB + BC30</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age

          -  Member of the same unit of the IDF

        Exclusion Criteria:

          -  Current use of dietary supplements

          -  Current chronic use of medications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jay R Hoffman, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Cenral Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Israel</name>
      <address>
        <city>Beersheva</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2016</study_first_submitted>
  <study_first_submitted_qc>May 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2016</study_first_posted>
  <last_update_submitted>January 27, 2017</last_update_submitted>
  <last_update_submitted_qc>January 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

